Economic burden and health-related quality of life in tenosynovial giant-cell tumour patients in Europe: an observational disease registry.

J Lopez-BastidaIsaac Aranda-ReneoB Rodríguez-SánchezL M Peña-LongobardoX YeP LaeisE M FronkE PalmeriniA LeithnerM A J Van de Sande

Published in: Orphanet journal of rare diseases (2021)

The results suggest that TGCT places a heavy burden on its sufferers, which increases after one year of follow-up, mainly due to the healthcare resources required-in particular, surgical procedures. As a result, this condition has a high economic impact on healthcare budgets, while the HRQOL of TGCT patients substantially deteriorates over time.

Keyphrases

healthcare
end stage renal disease
giant cell
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
risk factors